ArticleInternational journal of cardiology. Heart & vasculature2024

Inhibitory effect of rivaroxaban on protease-activated receptor-2 in circulating neutrophils among patients with atrial fibrillation.

Makoto Nakano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.